Smaller Sales Staffs Expected With More Targeted Marketing Under FDAAA
Executive Summary
Pharmaceutical company sales staffs will be significantly downsized as a result of the risk evaluation and management strategies imposed under the FDA Amendments Act, former Novartis Senior VP Nancy Lurker predicts